This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Selection of patients

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • patients have end-stage cardiac disease
  • must consider the likelihood of improved survival with a heart transplantation compared with the expected survival without a transplant. Survival with a transplant is approximately 80%, 70% and 55% at 1, 5 and 10 years respectively. A heart transplant must make a significant difference with respect to expected patient survival.
  • different aetiologies of patients who have heart transplants include:
    • ischaemic heart disease (about 50%)
    • cardiomyopathies (about 40%)
    • valvular and congenital heart defects (about 5%)
  • upper age limit is usually taken at about 60 years of age
  • absolute contraindications include:
    • serious concomitant pulmonary pathology eg pulmonary hypertension, parenchymal pulmonary disease, recent pulmonary embolism/infarction
    • active infection
    • a continued excess alcohol consumption
    • significant cerebral/systemic vascular disease
    • malignancy

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.